228 related articles for article (PubMed ID: 36459648)
1. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer.
Zhang J; Huang J; Xu K; Xing P; Huang Y; Liu Z; Tong L; Manley JL
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2216712119. PubMed ID: 36459648
[No Abstract] [Full Text] [Related]
2. Characterization of the SF3B1-SUGP1 interface reveals how numerous cancer mutations cause mRNA missplicing.
Zhang J; Xie J; Huang J; Liu X; Xu R; Tholen J; Galej WP; Tong L; Manley JL; Liu Z
Genes Dev; 2023 Dec; 37(21-24):968-983. PubMed ID: 37977822
[TBL] [Abstract][Full Text] [Related]
3. AI-assisted proofreading of RNA splicing.
Guerra-Moreno Á; Valcárcel J
Genes Dev; 2023 Dec; 37(21-24):945-947. PubMed ID: 38092520
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis identifies mutations in
Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
[TBL] [Abstract][Full Text] [Related]
5. Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.
Zhang J; Ali AM; Lieu YK; Liu Z; Gao J; Rabadan R; Raza A; Mukherjee S; Manley JL
Mol Cell; 2019 Oct; 76(1):82-95.e7. PubMed ID: 31474574
[TBL] [Abstract][Full Text] [Related]
6. Splicing quality control mediated by DHX15 and its G-patch activator SUGP1.
Feng Q; Krick K; Chu J; Burge CB
Cell Rep; 2023 Oct; 42(10):113223. PubMed ID: 37805921
[TBL] [Abstract][Full Text] [Related]
7. Splicing factor DHX15 affects tp53 and mdm2 expression via alternate splicing and promoter usage.
McElderry J; Carrington B; Bishop K; Kim E; Pei W; Chen Z; Ramanagoudr-Bhojappa R; Prakash A; Burgess SM; Liu PP; Sood R
Hum Mol Genet; 2019 Dec; 28(24):4173-4185. PubMed ID: 31691804
[TBL] [Abstract][Full Text] [Related]
8. SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing.
Tang Q; Rodriguez-Santiago S; Wang J; Pu J; Yuste A; Gupta V; Moldón A; Xu YZ; Query CC
Genes Dev; 2016 Dec; 30(24):2710-2723. PubMed ID: 28087715
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
Alsafadi S; Dayot S; Tarin M; Houy A; Bellanger D; Cornella M; Wassef M; Waterfall JJ; Lehnert E; Roman-Roman S; Stern MH; Popova T
Oncogene; 2021 Jan; 40(1):85-96. PubMed ID: 33057152
[TBL] [Abstract][Full Text] [Related]
10. SF3B1 mutant myelodysplastic syndrome: Recent advances.
Pellagatti A; Boultwood J
Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly.
Yang F; Bian T; Zhan X; Chen Z; Xing Z; Larsen NA; Zhang X; Shi Y
Nat Commun; 2023 Feb; 14(1):897. PubMed ID: 36797247
[TBL] [Abstract][Full Text] [Related]
13. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.
Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA
Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for DEAH-helicase activation by G-patch proteins.
Studer MK; Ivanović L; Weber ME; Marti S; Jonas S
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7159-7170. PubMed ID: 32179686
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
Liu YC; Illar GM; Bailey NG
J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616
[TBL] [Abstract][Full Text] [Related]
16. Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae.
Kaur H; Groubert B; Paulson JC; McMillan S; Hoskins AA
PLoS One; 2020; 15(4):e0229315. PubMed ID: 32320410
[TBL] [Abstract][Full Text] [Related]
17. The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts.
Choi IY; Ling JP; Zhang J; Helmenstine E; Walter W; Tsakiroglou P; Bergman RE; Philippe C; Manley JL; Rouault-Pierre K; Li B; Wiseman DH; Batta K; Ouseph MM; Bernard E; Dubner B; Li X; Haferlach T; Koget A; Fazal S; Jain T; Gocke CD; DeZern AE; Dalton WB
Blood Adv; 2024 May; ():. PubMed ID: 38759096
[TBL] [Abstract][Full Text] [Related]
18. RNA helicase DHX15 exemplifies a unique dependency in acute leukemia.
Guo H; Xu J; Xing P; Li Q; Wang D; Tang C; Palhais B; Roels J; Liu J; Pan S; Huang J; Liu Z; Zhu P; Taghon T; Qing G; Van Vlierberghe P; Liu H
Haematologica; 2023 Aug; 108(8):2029-2043. PubMed ID: 36861414
[TBL] [Abstract][Full Text] [Related]
19. The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.
Loerch S; Leach JR; Horner SW; Maji D; Jenkins JL; Pulvino MJ; Kielkopf CL
J Biol Chem; 2019 Feb; 294(8):2892-2902. PubMed ID: 30567737
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
